UBS Group’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,005
Closed -$159K 7936
2020
Q3
$159K Sell
3,005
-750
-20% -$39.7K ﹤0.01% 4110
2020
Q2
$230K Sell
3,755
-1,940
-34% -$119K ﹤0.01% 3920
2020
Q1
$322K Sell
5,695
-12,148
-68% -$687K ﹤0.01% 3547
2019
Q4
$1.02M Buy
17,843
+1,900
+12% +$108K ﹤0.01% 3325
2019
Q3
$853K Buy
15,943
+4,033
+34% +$216K ﹤0.01% 3309
2019
Q2
$711K Buy
11,910
+3,325
+39% +$198K ﹤0.01% 3284
2019
Q1
$535K Buy
8,585
+4,800
+127% +$299K ﹤0.01% 3327
2018
Q4
$229K Buy
3,785
+507
+15% +$30.7K ﹤0.01% 4025
2018
Q3
$192K Buy
3,278
+633
+24% +$37.1K ﹤0.01% 4267
2018
Q2
$119K Sell
2,645
-1,789
-40% -$80.5K ﹤0.01% 4444
2018
Q1
$197K Sell
4,434
-1,208
-21% -$53.7K ﹤0.01% 3995
2017
Q4
$244K Sell
5,642
-722
-11% -$31.2K ﹤0.01% 3893
2017
Q3
$296K Sell
6,364
-597
-9% -$27.8K ﹤0.01% 3769
2017
Q2
$344K Buy
6,961
+757
+12% +$37.4K ﹤0.01% 3588
2017
Q1
$340K Sell
6,204
-761
-11% -$41.7K ﹤0.01% 3515
2016
Q4
$388K Buy
6,965
+1,207
+21% +$67.2K ﹤0.01% 3486
2016
Q3
$263K Buy
5,758
+196
+4% +$8.95K ﹤0.01% 3546
2016
Q2
$222K Buy
5,562
+219
+4% +$8.74K ﹤0.01% 3692
2016
Q1
$186K Buy
5,343
+841
+19% +$29.3K ﹤0.01% 3822
2015
Q4
$194K Sell
4,502
-889
-16% -$38.3K ﹤0.01% 3790
2015
Q3
$234K Buy
5,391
+2,882
+115% +$125K ﹤0.01% 3599
2015
Q2
$129K Buy
2,509
+2,350
+1,478% +$121K ﹤0.01% 4140
2015
Q1
$6K Sell
159
-76
-32% -$2.87K ﹤0.01% 6134
2014
Q4
$9K Buy
+235
New +$9K ﹤0.01% 6069